MRNA logo

MRNA
Moderna Inc

110,962
Mkt Cap
$18.75B
Volume
4.22M
52W High
$59.55
52W Low
$22.28
PE Ratio
-5.75
MRNA Fundamentals
Price
$46.88
Prev Close
$47.26
Open
$47.54
50D MA
$50.62
Beta
1.36
Avg. Volume
5.54M
EPS (Annual)
-$7.25
P/B
2.51
Rev/Employee
$413,617.02
$6,976.61
Loading...
Loading...
News
all
press releases
Moderna Flu Shot Heads To FDA Advisory Panel
FDA to review Moderna's experimental mRNA flu shot on June 18 as the agency signals a more transparent approval process.read more...
News Placeholder
More News
News Placeholder
Notable Thursday Option Activity: MRNA, WDAY, LITE
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Moderna Inc (Symbol: MRNA), where a total volume of 50,006 contracts has been traded thus far today, a contract volume which is representative of approximately 5...
News Placeholder
MRNA Stock Slips: FDA Slates Advisory Hearing On Experimental Flu Shot
The Food and Drug Administration is eyeing a meeting on June 18 to discuss mRNA-1010.
News Placeholder
Top Research Reports for Visa, IBM & CrowdStrike
Visa stays central to digital payments as cross-border activity and transaction growth fuel momentum despite margin pressure.
News Placeholder
Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism
The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare as breakthroughs in immunotherapy, regenerative medicine, cell engineering, and AI-assisted drug development continue reshaping investor sentiment. Unlike traditional pharmaceutical compounds, biologics leverage complex biological systems to target diseases with greater specificity, opening new opportunities in cancer, autoimmune disorders, rare diseases, and regenerative therapies. $HCWB, $TGNT, $MRNA, $REGN
News Placeholder
Ralph Baric And UNC's Biodefense Contract Racket Exposed
Ralph Baric And UNC's Biodefense Contract Racket Exposed Authored by Paul D. Thacker via The DisInformation Chronicle, DLA Piper wants to get you, I was told, from a source in DC over the weekend...
News Placeholder
Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences
Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences...
News Placeholder
Moderna's Revenues See Strong International Momentum in Q1 Earnings
MRNA's Q1 revenues soar 260% on strong international vaccine sales, while cost cuts and new EU approvals support its broader growth strategy.
News Placeholder
MRNA Stock Closes Down On Profit-Taking Following 20% Weekly Rally And Hantavirus Buzz
One U.S. citizen has tested mildly positive for the Andes strain of hantavirus, U.S. health officials said Sunday.
News Placeholder
Trump Rejects Iran Offer as Tensions Rise Open Interest 5/11/2026
Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Oil jumps as President Trump calls Iran's latest peace offer totally unacceptable. Moderna...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available